Publication | Closed Access
A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo
30
Citations
36
References
2014
Year
Tumor BiologyOncologyEnhanced ActivityMedicineMelanomaMgmt-positive MelanomaTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyNovel Temozolomide AnalogCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1